<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Acute kidney injury (AKI) in minimal change disease and other forms of nephrotic syndrome
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Acute kidney injury (AKI) in minimal change disease and other forms of nephrotic syndrome
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Acute kidney injury (AKI) in minimal change disease and other forms of nephrotic syndrome
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Alain Meyrier, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jai Radhakrishnan, MD, MS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Richard J Glassock, MD, MACP
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Fernando C Fervenza, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Albert Q Lam, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Apr 07, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although the glomeruli are normal on light microscopy in minimal change disease (MCD) at the time of presentation, many adults and children have a modest reduction (averaging 30 percent) in glomerular filtration rate (GFR), as evidenced by a moderate elevation in the plasma creatinine concentration [
         <a href="#rid1">
          1-6
         </a>
         ]. This relatively common change is mediated at least in part by the reversible podocyte foot process fusion, which is apparent by electron microscopy, and which is characteristic of the disease [
         <a href="#rid7">
          7-11
         </a>
         ]. In addition to this modest reduction in GFR, some patients with MCD develop acute kidney injury (AKI), which is often severe and may require dialysis [
         <a href="#rid12">
          12-15
         </a>
         ]. In most cases, AKI is due to acute tubular necrosis.
        </p>
        <p>
         The pathophysiology, etiology, clinical manifestations, and treatment of GFR reduction in patients with MCD are discussed in this topic. The pathophysiology and treatment of edema in such patients, as well as treatment of MCD in children and adults, are presented elsewhere:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3044.html" rel="external">
          "Pathophysiology and treatment of edema in adults with the nephrotic syndrome"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6130.html" rel="external">
          "Treatment of idiopathic nephrotic syndrome in children"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3045.html" rel="external">
          "Minimal change disease: Treatment in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3345421990">
         <span class="h1">
          PATHOPHYSIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many patients with MCD and nephrotic syndrome have a modest reduction in glomerular filtration rate (GFR) of approximately 30 percent [
         <a href="#rid1">
          1-6
         </a>
         ]. Studies of children with this disorder show a close correlation of the GFR with both the reduced filtration fraction and the decreased serum albumin concentration that are proportional to the severity of the nephrotic state [
         <a href="#rid6">
          6-8,10
         </a>
         ]. The driving force for glomerular filtration is the difference in hydrostatic pressure and oncotic pressure across the glomerular capillary. In severe nephrotic syndrome with MCD, oncotic pressure is greatly reduced due to leakage of albumin into the Bowman's space, which could lead to a drop in ultrafiltration across the glomerular basement membrane [
         <a href="#rid16">
          16
         </a>
         ]. Filtrate that has passed through the glomerular basement membrane enters the urinary space via the slit pores between the adjacent foot processes. Foot process fusion decreases the filtration slit frequency, thereby increasing the average path length for filtration [
         <a href="#rid7">
          7,8,10
         </a>
         ]. The capacity of the glomerular basement membrane to bar the egress of serum albumin into Bowman's space is altered, causing massive proteinuria, while foot process fusion reduces the glomerular capillary wall permeability to water and small solutes, decreasing hydraulic permeability and explaining the reduction in the GFR.
        </p>
        <p>
         Low effective arterial blood volume is
         <strong>
          not
         </strong>
         the cause of reduced GFR in most patients with MCD. Although patients with MCD have a low plasma oncotic pressure, the "underfill" hypothesis that was thought to explain the reduction in GFR and the intense renal sodium reabsorption is no longer accepted [
         <a href="#rid17">
          17-34
         </a>
         ]. Rather, in this particular edematous state, an increase in the interstitial pressure is accompanied by an increase of the lymph flow to the circulation that maintains a normal blood volume [
         <a href="#rid15">
          15
         </a>
         ]. These changes in kidney function regress with treatment-induced remission of proteinuria. (See
         <a class="medical medical_review" href="/z/d/html/3044.html" rel="external">
          "Pathophysiology and treatment of edema in adults with the nephrotic syndrome"
         </a>
         .)
        </p>
        <p>
         In some patients with MCD (usually adults), an acute onset of a severe decline in GFR is seen, possibly requiring dialysis. As noted below, hypertension and older age are risk factors for AKI in patients with MCD. In several studies, for example, kidney biopsies performed in patients with MCD and AKI revealed vascular lesions of arterial and arteriolar sclerosis, which are commonly found in hypertensives [
         <a href="#rid13">
          13,35
         </a>
         ]. These lesions of the renal vessels contribute to reduced blood flow to the glomeruli [
         <a href="#rid36">
          36
         </a>
         ], which diminish in number with aging [
         <a href="#rid37">
          37
         </a>
         ]. In addition, tubulointerstitial lesions are common with hypertensive nephrosclerosis [
         <a href="#rid36">
          36
         </a>
         ]. Underlying vascular disease and tubulointerstitial lesions may be an important precursor to the development of AKI in patients with MCD.
        </p>
        <p class="headingAnchor" id="H2010627289">
         <span class="h1">
          EPIDEMIOLOGY, ETIOLOGY, AND CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many adults and children with MCD have a modest, persistent reduction in glomerular filtration rate (GFR), as evidenced by a moderate elevation in the plasma creatinine concentration. However, despite normal glomeruli by light microscopy, some patients with MCD develop AKI, which is often severe and may require dialysis.
        </p>
        <p>
         The simultaneous presence of AKI and nephrotic syndrome should raise suspicion for MCD, particularly among older adults. In one large series, for example, 5 of 20 patients biopsied because of AKI and nephrotic syndrome had a diagnosis of MCD; two had pauci-immune glomerulonephritis, and no other etiology of nephrotic syndrome accounted for more than one case [
         <a href="#rid38">
          38
         </a>
         ]. The likelihood of MCD is even higher in nephrotic patients with acute tubular necrosis as the cause of AKI (15 of 19 in one study) [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4236554833">
         <span class="h2">
          Acute kidney injury in adults with minimal change disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         AKI has been reported in approximately 25 to 35 percent of adults with MCD and is frequently present at the time the nephrotic syndrome is diagnosed [
         <a href="#rid12">
          12,14,40,41
         </a>
         ]. Patients with MCD who develop AKI are more likely than those who do not develop AKI to be older, male, hypertensive, and to have more severe nephrotic syndrome [
         <a href="#rid15">
          15,42
         </a>
         ]. As an example, in one retrospective review of 95 adults with MCD from the United States [
         <a href="#rid14">
          14
         </a>
         ], AKI occurred in 24 patients (25 percent). In 17 patients, it was concurrent with the initial presentation of MCD, and in seven patients, it occurred during a relapse of MCD. Patients with AKI were older (54 versus 42 years) and were more likely to be male (63 versus 33 percent) and hypertensive (69 versus 37 percent). In addition, proteinuria was higher among those with AKI (13 versus 9 g/day). In another series of 125 adults and adolescents (age &gt;16 years) from the Netherlands, AKI was observed in 50 patients (40 percent) [
         <a href="#rid42">
          42
         </a>
         ]. Median time to recovery of kidney function was six weeks. Nine patients required hemodialysis; eight recovered kidney function, and one died from infectious complications while on dialysis.
        </p>
        <p>
         Most patients presenting with AKI in the setting of MCD have substantial proteinuria, hypoalbuminemia, and edema. In a large series of 75 adults with MCD who developed AKI, the mean urine protein excretion was 12 g/day and the serum albumin was 1.9 g/dL (19 g/L) [
         <a href="#rid12">
          12
         </a>
         ]. Approximately one-half of patients had hypertension at the time of presentation, and 84 percent had massive edema. All cases of AKI occurred within three months of the time that the nephrotic syndrome was diagnosed (mean of 29 days). AKI was severe; most patients were oliguric at presentation, and approximately 20 percent required dialysis or died from intercurrent complications.
        </p>
        <p>
         The usual etiologies of AKI in adults with MCD are as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acute tubular necrosis
         </strong>
         – Most reported patients appear to have tubular changes that are similar to those in postischemic acute tubular necrosis [
         <a href="#rid12">
          12-14,35,40
         </a>
         ]. In the study of 75 adults with MCD and AKI mentioned above, acute tubular necrosis was the cause of AKI in 65 percent of patients [
         <a href="#rid12">
          12
         </a>
         ]. By contrast, tubular injury is not seen in kidney biopsies of patients with MCD who maintain relatively normal kidney function. These observations suggest that transient ischemia may occur early in the course of the disease. In one study of 53 patients with MCD, one-half had AKI [
         <a href="#rid41">
          41
         </a>
         ]. Among those with AKI, immunostaining for endothelin-1 (ET-1) revealed strongly positive staining on tubules, whose cells were flattened or necrotic. This raised the hypothesis that in some patients with MCD, a surge of ET-1 secretion induces vasoconstriction and ischemia at the onset of proteinuria [
         <a href="#rid15">
          15
         </a>
         ]. Older patients who develop this complication also tend to have underlying arteriolar nephrosclerosis, which might predispose to decreased nephron perfusion [
         <a href="#rid12">
          12,35
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nonsteroidal antiinflammatory drugs (NSAIDs)
         </strong>
         – NSAIDs can diminish kidney function by decreasing the formation of vasodilator prostaglandins, thereby inducing renal vasoconstriction; this may induce ischemic tubular injury [
         <a href="#rid43">
          43
         </a>
         ]. NSAIDs may also cause MCD as a toxic effect of therapy [
         <a href="#rid44">
          44-48
         </a>
         ]. The latter complication is most often seen with
         <a class="drug drug_general" data-topicid="8440" href="/z/d/drug information/8440.html" rel="external">
          fenoprofen
         </a>
         and is typically accompanied by an acute interstitial nephritis that is responsible for the kidney failure [
         <a href="#rid49">
          49
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7230.html" rel="external">
          "NSAIDs: Acute kidney injury"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Although most common with NSAIDs, the combination of acute interstitial nephritis and MCD can also be induced by other drugs. (See
         <a class="medical medical_review" href="/z/d/html/7234.html" rel="external">
          "Clinical manifestations and diagnosis of acute interstitial nephritis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Contrast-induced nephropathy
         </strong>
         – Nephrotic patients, particularly those with diabetes mellitus, are especially prone to AKI following iodinated contrast media-enhanced radiographic procedures. (See
         <a class="medical medical_review" href="/z/d/html/7241.html" rel="external">
          "Contrast-associated and contrast-induced acute kidney injury: Clinical features, diagnosis, and management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7221.html" rel="external">
          "Prevention of contrast-associated acute kidney injury related to angiography"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Excessive diuresis
         </strong>
         – Natriuresis induced by loop diuretics can lead to plasma volume depletion and a decline in kidney function. This problem is most likely to occur in patients with a plasma albumin concentration of 1.5 g/dL (15 g/L) or less [
         <a href="#rid50">
          50
         </a>
         ]. In most patients, however, the hypoalbuminemia is less severe. In addition, edema and renal sodium retention in MCD are primarily due to a direct effect of glomerular albumin leak on the renal tubules, rather than a decrease in plasma oncotic pressure and, consequently, reduced effective arterial blood volume [
         <a href="#rid18">
          18,19,28-33
         </a>
         ]. Thus, such patients are generally at low risk of hypovolemia following fluid removal with diuretics [
         <a href="#rid17">
          17,26
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3044.html" rel="external">
          "Pathophysiology and treatment of edema in adults with the nephrotic syndrome"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Increased urine viscosity
         </strong>
         – In nephrotic patients with oliguria and an unusually high degree of proteinuria, urine viscosity may contribute to impair kidney function. This is illustrated by a case in which a patient with AKI voided small amounts of gel-like urine with &gt;120 g/L of albumin [
         <a href="#rid51">
          51
         </a>
         ]. Kidney function recovered with a glucocorticoid-induced remission of proteinuria.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2334950701">
         <span class="h2">
          Acute kidney injury in children with minimal change disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         AKI is much less frequent in children with MCD as compared with adults. In one study of 1006 children with idiopathic nephrotic syndrome, the nine-year incidence of AKI was 0.8 percent [
         <a href="#rid52">
          52
         </a>
         ]. As noted above, approximately 25 to 35 percent of adults with MCD develop AKI. (See
         <a class="local">
          'Acute kidney injury in adults with minimal change disease'
         </a>
         above.)
        </p>
        <p>
         Conversely, AKI is common when children with MCD are hospitalized for complications of nephrotic syndrome, such as infection or thrombosis. As an example, in a multicenter study of 336 children with nephrotic syndrome, 197 developed AKI (59 percent) [
         <a href="#rid53">
          53
         </a>
         ]. Common causes of AKI in these children include hypovolemia (due to diarrhea, vomiting, or excessive diuresis), infection (typically, pneumonia or peritonitis), nephrotoxic medications (such as NSAIDs), and the effects of drugs such as calcineurin inhibitors and angiotensin-converting enzyme (ACE) inhibitors [
         <a href="#rid53">
          53-62
         </a>
         ].
        </p>
        <p>
         Changes in glomerular permeability may underlie AKI in some children. In one study of 11 children with MCD and oliguric AKI [
         <a href="#rid63">
          63
         </a>
         ], for example, measured renal plasma flow at presentation was normal, and neither renal plasma flow nor filtration fraction improved after volume expansion with 20 percent albumin. This indicated that decreased renal perfusion was not contributing to the reduction in GFR. Rather, these findings are consistent with a principal role for reduced glomerular capillary loops permeability due to foot process fusion in the pathogenesis of the reduced GFR [
         <a href="#rid7">
          7-11
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3036600659">
         <span class="h2">
          Acute kidney injury in other forms of nephrotic syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         AKI is unusual in other pure nephrotic states (ie, patients with a normal or near-normal urine sediment) such as diabetic nephropathy and amyloidosis.
        </p>
        <p>
         There are, however, two major settings in which AKI can occur in pure nephrotic syndrome:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In patients with the collapsing form of focal segmental glomerulosclerosis in which renal insufficiency is due both to glomerular and concurrent tubular injury. This disorder is often associated with HIV infection but may occur in the absence of this infection. (See
         <a class="medical medical_review" href="/z/d/html/14026.html" rel="external">
          "HIV-associated nephropathy (HIVAN)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3080.html" rel="external">
          "Collapsing focal segmental glomerulosclerosis (collapsing glomerulopathy)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In some patients treated with NSAIDs [
         <a href="#rid64">
          64
         </a>
         ]. These drugs reduce the GFR and may induce an acute kidney functional impairment that is reversible after stopping the medication. Conversely, NSAIDs may cause an acute allergic interstitial nephritis, which regresses slowly following treatment with glucocorticoids, although patients with interstitial nephritis do not have a normal urine sediment. (See
         <a class="medical medical_review" href="/z/d/html/7230.html" rel="external">
          "NSAIDs: Acute kidney injury"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Other, less common causes of AKI in conjunction with nephrotic syndrome include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Allergic reactions to drugs that are commonly used in treatment of nephrotic syndrome (such as
         <a class="drug drug_general" data-topicid="8482" href="/z/d/drug information/8482.html" rel="external">
          furosemide
         </a>
         , thiazide diuretics, or
         <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">
          warfarin
         </a>
         ) may occasionally produce AKI due to a hypersensitivity interstitial nephritis. Skin rash and eosinophilia may accompany these reactions. (See
         <a class="medical medical_review" href="/z/d/html/7234.html" rel="external">
          "Clinical manifestations and diagnosis of acute interstitial nephritis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         AKI due to crescentic glomerulonephritis has rarely been described in patients with membranous nephropathy (MN). In this setting, the urinalysis reveals an active sediment (red cells and granular and cellular casts) rather than a bland urine sediment as seen in most patients with AKI associated with nephrotic syndrome. (See
         <a class="medical medical_review" href="/z/d/html/3113.html" rel="external">
          "Overview of the classification and treatment of rapidly progressive (crescentic) glomerulonephritis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Renal vein thrombosis is also a rare cause of AKI in the nephrotic syndrome. However, most patients with this complication have relatively stable kidney function; an elevation in the plasma creatinine concentration primarily occurs in the exceptional patient with acute bilateral renal vein thrombosis that produces renal infarction and flank pain before the development of a collateral venous circulation relieves the intrarenal venous pressure. (See
         <a class="medical medical_review" href="/z/d/html/119627.html" rel="external">
          "Renal vein thrombosis in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2889906251">
         <span class="h1">
          EVALUATION AND DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The evaluation of patients with nephrotic syndrome who develop AKI depends in part upon whether or not the cause of the nephrotic syndrome is already known:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If the cause of nephrotic syndrome is not already known, then a kidney biopsy is typically performed to identify the etiology of both the nephrotic syndrome and the AKI.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If the cause of nephrotic syndrome is already known (eg, in a patient with an established diagnosis of MCD), the initial evaluation is similar to that in patients without nephrotic syndrome. (See
         <a class="medical medical_review" href="/z/d/html/102834.html" rel="external">
          "Evaluation of acute kidney injury among hospitalized adult patients", section on 'Evaluation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7188.html" rel="external">
          "Diagnostic approach to adult patients with subacute kidney injury in an outpatient setting", section on 'Evaluation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7216.html" rel="external">
          "Etiology and diagnosis of prerenal disease and acute tubular necrosis in acute kidney injury in adults", section on 'Evaluation and diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If the evaluation of AKI reveals prerenal azotemia, acute tubular necrosis, or obstructive uropathy, a kidney biopsy is not usually needed. Other patients typically undergo kidney biopsy to determine the etiology of AKI.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          TREATMENT AND PROGNOSIS
         </span>
        </p>
        <p class="headingAnchor" id="H2111613452">
         <span class="h2">
          AKI in patients with minimal change disease
         </span>
        </p>
        <p class="headingAnchor" id="H1849979115">
         <span class="h3">
          Treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Therapy of AKI is aimed at inducing a remission of the nephrotic syndrome, eliminating factors that could potentially be contributing to the renal impairment, and treating the complications of AKI.
        </p>
        <p>
         Therapy to induce remission in patients with MCD is discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/3045.html" rel="external">
          "Minimal change disease: Treatment in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6130.html" rel="external">
          "Treatment of idiopathic nephrotic syndrome in children"
         </a>
         .)
        </p>
        <p>
         Factors that could contribute to AKI in patients with MCD, such as infection, should be treated appropriately. Nephrotoxic medications (such as nonsteroidal antiinflammatory drugs [NSAIDs]) or drugs that could contribute to functional azotemia (such as angiotensin-converting enzyme [ACE] inhibitors) should be discontinued. In addition, volume replacement is appropriate in patients who have developed a decline in kidney function that is temporally related to diuretic-induced fluid removal. However, infusing albumin is not useful, as it is rapidly wasted in the urine and does not improve kidney function [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1016887791">
         <span class="h3">
          Prognosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         A majority of patients with MCD eventually go into remission, with disappearance of proteinuria, when receiving immunosuppressive therapy [
         <a href="#rid1">
          1,2,42,66
         </a>
         ]; approximately two-thirds of such patients with AKI recover to normal or near-normal kidney function within an average of seven weeks. However, short-term dialysis may be required in selected cases [
         <a href="#rid12">
          12,13
         </a>
         ]. Patients who suffer an episode of AKI compared with those without such an event have significantly higher serum creatinine levels over the long term [
         <a href="#rid35">
          35,67
         </a>
         ].
        </p>
        <p>
         In large series of patients with MCD, for example, 75 developed AKI, four of whom required hemodialysis for a period that ranged from 5 to 24 weeks [
         <a href="#rid12">
          12
         </a>
         ]. Overall, the time between onset of AKI and recovery was 47 days (range of 3 to 180 days). At more than four years of follow-up, the mean serum creatinine in these 75 patients with an episode of AKI was significantly higher compared with patients who had MCD but no AKI.
        </p>
        <p>
         Chronic kidney disease is a rare event [
         <a href="#rid12">
          12-14,67
         </a>
         ] that occurs most often in patients with focal segmental glomerulosclerosis, either as the primary disease (segmental sclerotic lesions can easily be missed on percutaneous kidney biopsy) or as a consequence of the tubular epithelial cell injury in initial MCD [
         <a href="#rid68">
          68
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3049.html" rel="external">
          "Focal segmental glomerulosclerosis: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
         Some patients with MCD develop AKI that is irreversible [
         <a href="#rid14">
          14,67
         </a>
         ]. One study reported five such cases in adults aged 44 to 74 years [
         <a href="#rid67">
          67
         </a>
         ]. Prior kidney disease or occlusion of major renal vasculature was not present. These patients continued to excrete large amounts of protein (9 to 15 g/day) despite a low glomerular filtration rate (GFR) and severe oliguria. One patient died after five months without recovering kidney function. Four patients required hemodialysis for a period of 12 to 58 months.
        </p>
        <p>
         The overall impression is that recovery of kidney function was achieved in approximately two-thirds of the cases within an average of seven weeks, but with wide variations in this length of time. Fourteen patients died of various complications, and some remained indefinitely on dialysis. These patients who did not recover were older and more hypertensive than those who recovered.
        </p>
        <p class="headingAnchor" id="H1897400149">
         <span class="h2">
          AKI in patients with other forms of nephrotic syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         The treatment of AKI in patients with other forms of nephrotic syndrome depends upon the etiology of the AKI:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Collapsing focal segmental glomerulosclerosis (see
         <a class="medical medical_review" href="/z/d/html/3080.html" rel="external">
          "Collapsing focal segmental glomerulosclerosis (collapsing glomerulopathy)", section on 'Treatment'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14026.html" rel="external">
          "HIV-associated nephropathy (HIVAN)", section on 'Treatment'
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         NSAIDs (see
         <a class="medical medical_review" href="/z/d/html/7230.html" rel="external">
          "NSAIDs: Acute kidney injury", section on 'Treatment'
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Allergic interstitial nephritis (see
         <a class="medical medical_review" href="/z/d/html/7233.html" rel="external">
          "Treatment of acute interstitial nephritis"
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Crescentic glomerulonephritis (see
         <a class="medical medical_review" href="/z/d/html/3113.html" rel="external">
          "Overview of the classification and treatment of rapidly progressive (crescentic) glomerulonephritis", section on 'Treatment'
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Renal vein thrombosis (see
         <a class="medical medical_review" href="/z/d/html/119627.html" rel="external">
          "Renal vein thrombosis in adults", section on 'Treatment'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Overview
         </strong>
         – Many adults and children with minimal change disease (MCD) and nephrotic syndrome have a modest reduction in glomerular filtration rate (GFR) of approximately 30 percent, as evidenced by a moderate elevation in the plasma creatinine concentration. This relatively common change is mediated at least in part by the reversible podocyte foot process fusion. In addition to this modest reduction in GFR, some patients with MCD develop acute kidney injury (AKI), which is often severe and may require dialysis. (See
         <a class="local">
          'Pathophysiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          AKI in adults with MCD
         </strong>
         – Most adults presenting with AKI in the setting of MCD have substantial proteinuria, hypoalbuminemia, and edema. The usual etiologies of AKI include acute tubular necrosis, nonsteroidal antiinflammatory drugs (NSAIDs), contrast-induced nephropathy, and excessive diuresis (most often in patients with a plasma albumin concentration ≤1.5 g/dL [15 g/L]). (See
         <a class="local">
          'Acute kidney injury in adults with minimal change disease'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          AKI in children with MCD
         </strong>
         – AKI is much less frequent in children with MCD as compared with adults but is common when children with MCD are hospitalized for complications of nephrotic syndrome, such as infection or thrombosis. Common causes of AKI in these children include hypovolemia (due to diarrhea, vomiting, or excessive diuresis), infection (typically pneumonia or peritonitis), nephrotoxic medications (such as NSAIDs), and the effects of drugs such as calcineurin inhibitors and angiotensin-converting enzyme (ACE) inhibitors. (See
         <a class="local">
          'Acute kidney injury in children with minimal change disease'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          AKI in other forms of nephrotic syndrome
         </strong>
         – AKI is unusual in other pure nephrotic states although it may be seen in patients with the collapsing form of focal segmental glomerulosclerosis, patients treated with NSAIDs, patients who have an allergic interstitial nephritis induced by medications used to treat nephrotic syndrome (such as
         <a class="drug drug_general" data-topicid="8482" href="/z/d/drug information/8482.html" rel="external">
          furosemide
         </a>
         ), patients with crescentic transformation of membranous nephropathy, and patients who develop renal vein thrombosis as a complication of nephrotic syndrome. (See
         <a class="local">
          'AKI in patients with other forms of nephrotic syndrome'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation
         </strong>
         – The evaluation of patients with nephrotic syndrome who develop AKI depends in part upon whether or not the cause of the nephrotic syndrome is already known (see
         <a class="local">
          'Evaluation and diagnosis'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         If the cause of nephrotic syndrome is not already known, then a kidney biopsy is typically performed to identify the etiology of both the nephrotic syndrome and the AKI.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         If the cause of nephrotic syndrome is already known, the initial evaluation is similar to that in patients without nephrotic syndrome.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
         – Therapy of AKI in patients with MCD is aimed at inducing a remission of the nephrotic syndrome, eliminating factors that could potentially be contributing to the kidney function impairment (eg, nephrotoxic medications, infection), and treating the complications of AKI. (See
         <a class="local">
          'Treatment'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Nolasco F, Cameron JS, Heywood EF, et al. Adult-onset minimal change nephrotic syndrome: a long-term follow-up. Kidney Int 1986; 29:1215.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hopper J Jr, Ryan P, Lee JC, Rosenau W. Lipoid nephrosis in 31 adult patients: renal biopsy study by light, electron, and fluorescence microscopy with experience in treatment. Medicine (Baltimore) 1970; 49:321.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           White RH, Glasgow EF, Mills RJ. Clinicopathological study of nephrotic syndrome in childhood. Lancet 1970; 1:1353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Habib R, Kleinknecht C. The primary nephrotic syndrome of childhood. Classification and clinicopathologic study of 406 cases. Pathol Annu 1971; 6:417.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 1978; 13:159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bohlin AB. Clinical course and renal function in minimal change nephrotic syndrome. Acta Paediatr Scand 1984; 73:631.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Drumond MC, Kristal B, Myers BD, Deen WM. Structural basis for reduced glomerular filtration capacity in nephrotic humans. J Clin Invest 1994; 94:1187.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bohman SO, Jaremko G, Bohlin AB, Berg U. Foot process fusion and glomerular filtration rate in minimal change nephrotic syndrome. Kidney Int 1984; 25:696.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deen WM. What determines glomerular capillary permeability? J Clin Invest 2004; 114:1412.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robson AM, Giangiacomo J, Kienstra RA, et al. Normal glomerular permeability and its modification by minimal change nephrotic syndrmone. J Clin Invest 1974; 54:1190.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shirato I. Podocyte process effacement in vivo. Microsc Res Tech 2002; 57:241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith JD, Hayslett JP. Reversible renal failure in the nephrotic syndrome. Am J Kidney Dis 1992; 19:201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jennette JC, Falk RJ. Adult minimal change glomerulopathy with acute renal failure. Am J Kidney Dis 1990; 16:432.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Waldman M, Crew RJ, Valeri A, et al. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol 2007; 2:445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meyrier A, Niaudet P. Acute kidney injury complicating nephrotic syndrome of minimal change disease. Kidney Int 2018; 94:861.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cameron MA, Peri U, Rogers TE, Moe OW. Minimal change disease with acute renal failure: a case against the nephrosarca hypothesis. Nephrol Dial Transplant 2004; 19:2642.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geers AB, Koomans HA, Roos JC, Dorhout Mees EJ. Preservation of blood volume during edema removal in nephrotic subjects. Kidney Int 1985; 28:652.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dorhout Mees EJ, Koomans HA. Understanding the nephrotic syndrome: what's new in a decade? Nephron 1995; 70:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eisenberg S. Blood volume in persons with the nephrotic syndrome. Am J Med Sci 1968; 255:320.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koomans HA, Kortlandt W, Geers AB, Dorhout Mees EJ. Lowered protein content of tissue fluid in patients with the nephrotic syndrome: observations during disease and recovery. Nephron 1985; 40:391.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koomans HA, Geers AB, Dorhout Mees EJ, Kortlandt W. Lowered tissue-fluid oncotic pressure protects the blood volume in the nephrotic syndrome. Nephron 1986; 42:317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vande Walle JG, Donckerwolcke RA. Pathogenesis of edema formation in the nephrotic syndrome. Pediatr Nephrol 2001; 16:283.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dorhout EJ, Roos JC, Boer P, et al. Observations on edema formation in the nephrotic syndrome in adults with minimal lesions. Am J Med 1979; 67:378.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dorhout Mees EJ, Geers AB, Koomans HA. Blood volume and sodium retention in the nephrotic syndrome: a controversial pathophysiological concept. Nephron 1984; 36:201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fauchald P, Noddeland H, Norseth J. Interstitial fluid volume, plasma volume and colloid osmotic pressure in patients with nephrotic syndrome. Scand J Clin Lab Invest 1984; 44:661.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geers AB, Koomans HA, Boer P, Dorhout Mees EJ. Plasma and blood volumes in patients with the nephrotic syndrome. Nephron 1984; 38:170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koomans HA, Braam B, Geers AB, et al. The importance of plasma protein for blood volume and blood pressure homeostasis. Kidney Int 1986; 30:730.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown EA, Markandu N, Sagnella GA, et al. Sodium retention in nephrotic syndrome is due to an intrarenal defect: evidence from steroid-induced remission. Nephron 1985; 39:290.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown EA, Markandu ND, Sagnella GA, et al. Evidence that some mechanism other than the renin system causes sodium retention in nephrotic syndrome. Lancet 1982; 2:1237.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fadnes HO, Pape JF, Sundsfjord JA. A study on oedema mechanism in nephrotic syndrome. Scand J Clin Lab Invest 1986; 46:533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geers AB, Koomans HA, Roos JC, et al. Functional relationships in the nephrotic syndrome. Kidney Int 1984; 26:324.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hammond TG, Whitworth JA, Saines D, et al. Renin-angiotensin-aldosterone system in nephrotic syndrome. Am J Kidney Dis 1984; 4:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ichikawa I, Rennke HG, Hoyer JR, et al. Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. J Clin Invest 1983; 71:91.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koomans HA, Boer WH, Dorhout Mees EJ. Renal function during recovery from minimal lesions nephrotic syndrome. Nephron 1987; 47:173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Esparza AR, Kahn SI, Garella S, Abuelo JG. Spectrum of acute renal failure in nephrotic syndrome with minimal (or minor) glomerular lesions. Role of hemodynamic factors. Lab Invest 1981; 45:510.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meyrier A. Nephrosclerosis: update on a centenarian. Nephrol Dial Transplant 2015; 30:1833.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Denic A, Lieske JC, Chakkera HA, et al. The Substantial Loss of Nephrons in Healthy Human Kidneys with Aging. J Am Soc Nephrol 2017; 28:313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moutzouris DA, Herlitz L, Appel GB, et al. Renal biopsy in the very elderly. Clin J Am Soc Nephrol 2009; 4:1073.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haas M, Spargo BH, Wit EJ, Meehan SM. Etiologies and outcome of acute renal insufficiency in older adults: a renal biopsy study of 259 cases. Am J Kidney Dis 2000; 35:433.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen T, Lv Y, Lin F, Zhu J. Acute kidney injury in adult idiopathic nephrotic syndrome. Ren Fail 2011; 33:144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen CL, Fang HC, Chou KJ, et al. Increased endothelin 1 expression in adult-onset minimal change nephropathy with acute renal failure. Am J Kidney Dis 2005; 45:818.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maas RJ, Deegens JK, Beukhof JR, et al. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series. Am J Kidney Dis 2017; 69:637.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Almansori M, Kovithavongs T, Qarni MU. Cyclooxygenase-2 inhibitor-associated minimal-change disease. Clin Nephrol 2005; 63:381.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1984; 310:563.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glassock RJ. Secondary minimal change disease. Nephrol Dial Transplant 2003; 18 Suppl 6:vi52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lafrance JP, Miller DR. Selective and non-selective non-steroidal anti-inflammatory drugs and the risk of acute kidney injury. Pharmacoepidemiol Drug Saf 2009; 18:923.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brezin JH, Katz SM, Schwartz AB, Chinitz JL. Reversible renal failure and nephrotic syndrome associated with nonsteroidal anti-inflammatory drugs. N Engl J Med 1979; 301:1271.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kleinknecht D. Interstitial nephritis, the nephrotic syndrome, and chronic renal failure secondary to nonsteroidal anti-inflammatory drugs. Semin Nephrol 1995; 15:228.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Curt GA, Kaldany A, Whitley LG, et al. Reversible rapidly progressive renal failure with nephrotic syndrome due to fenoprofen calcium. Ann Intern Med 1980; 92:72.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meltzer JI, Keim HJ, Laragh JH, et al. Nephrotic syndrome: vasoconstriction and hypervolemic types indicated by renin-sodium profiling. Ann Intern Med 1979; 91:688.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koomans HA. Pathophysiology of acute renal failure in idiopatic nephrotic syndrome. Nephrol Dial Transplant 2001; 16:221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kiliś-Pstrusińska K, Zwolińska D, Musiał K. [Acute renal failure in children with idiopathic nephrotic syndrome]. Pol Merkur Lekarski 2000; 8:462.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rheault MN, Zhang L, Selewski DT, et al. AKI in Children Hospitalized with Nephrotic Syndrome. Clin J Am Soc Nephrol 2015; 10:2110.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reimold EW, Marks JF. Hypovolemic shock complicating the nephrotic syndrome in children. J Pediatr 1966; 69:658.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Theuns-Valks SD, van Wijk JA, van Heerde M, et al. Abdominal pain and vomiting in a boy with nephrotic syndrome. Clin Pediatr (Phila) 2011; 50:470.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van de Walle JG, Donckerwolcke RA, Greidanus TB, et al. Renal sodium handling in children with nephrotic relapse: relation to hypovolaemic symptoms. Nephrol Dial Transplant 1996; 11:2202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang SJ, Tsau YK, Lu FL, Chen CH. Hypovolemia and hypovolemic shock in children with nephrotic syndrome. Acta Paediatr Taiwan 2000; 41:179.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rheault MN, Wei CC, Hains DS, et al. Increasing frequency of acute kidney injury amongst children hospitalized with nephrotic syndrome. Pediatr Nephrol 2014; 29:139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Agarwal N, Phadke KD, Garg I, Alexander P. Acute renal failure in children with idiopathic nephrotic syndrome. Pediatr Nephrol 2003; 18:1289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cavagnaro F, Lagomarsino E. Peritonitis as a risk factor of acute renal failure in nephrotic children. Pediatr Nephrol 2000; 15:248.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sakarcan A, Timmons C, Seikaly MG. Reversible idiopathic acute renal failure in children with primary nephrotic syndrome. J Pediatr 1994; 125:723.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sharma M, Mahanta A, Barman AK, Mahanta PJ. Acute kidney injury in children with nephrotic syndrome: a single-center study. Clin Kidney J 2018; 11:655.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vande Walle J, Mauel R, Raes A, et al. ARF in children with minimal change nephrotic syndrome may be related to functional changes of the glomerular basal membrane. Am J Kidney Dis 2004; 43:399.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bakhriansyah M, Souverein PC, van den Hoogen MWF, et al. Risk of Nephrotic Syndrome for Non-Steroidal Anti-Inflammatory Drug Users. Clin J Am Soc Nephrol 2019; 14:1355.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dorhout Mees EJ. Does it make sense to administer albumin to the patient with nephrotic oedema? Nephrol Dial Transplant 1996; 11:1224.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mak SK, Short CD, Mallick NP. Long-term outcome of adult-onset minimal-change nephropathy. Nephrol Dial Transplant 1996; 11:2192.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raij L, Keane WF, Leonard A, Shapiro FL. Irreversible acute renal failure in idiopathic nephrotic syndrome. Am J Med 1976; 61:207.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rennke HG, Klein PS. Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am J Kidney Dis 1989; 13:443.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 3047 Version 21.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3747335" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Adult-onset minimal change nephrotic syndrome: a long-term follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5426747" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Lipoid nephrosis in 31 adult patients: renal biopsy study by light, electron, and fluorescence microscopy with experience in treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4194123" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Clinicopathological study of nephrotic syndrome in childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4949371" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : The primary nephrotic syndrome of childhood. Classification and clinicopathologic study of 406 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/713276" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6485782" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Clinical course and renal function in minimal change nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8083359" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Structural basis for reduced glomerular filtration capacity in nephrotic humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6482174" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Foot process fusion and glomerular filtration rate in minimal change nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15545991" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : What determines glomerular capillary permeability?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4417621" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Normal glomerular permeability and its modification by minimal change nephrotic syndrmone.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12012392" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Podocyte process effacement in vivo.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1553965" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Reversible renal failure in the nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2239933" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Adult minimal change glomerulopathy with acute renal failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17699450" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29980292" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Acute kidney injury complicating nephrotic syndrome of minimal change disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15388821" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Minimal change disease with acute renal failure: a case against the nephrosarca hypothesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4087686" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Preservation of blood volume during edema removal in nephrotic subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7617085" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Understanding the nephrotic syndrome: what's new in a decade?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5650754" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Blood volume in persons with the nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4022206" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Lowered protein content of tissue fluid in patients with the nephrotic syndrome: observations during disease and recovery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3960243" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Lowered tissue-fluid oncotic pressure protects the blood volume in the nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11322379" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Pathogenesis of edema formation in the nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/474584" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Observations on edema formation in the nephrotic syndrome in adults with minimal lesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6369161" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Blood volume and sodium retention in the nephrotic syndrome: a controversial pathophysiological concept.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6531655" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Interstitial fluid volume, plasma volume and colloid osmotic pressure in patients with nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6493410" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Plasma and blood volumes in patients with the nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3784303" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : The importance of plasma protein for blood volume and blood pressure homeostasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3982574" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Sodium retention in nephrotic syndrome is due to an intrarenal defect: evidence from steroid-induced remission.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6128546" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Evidence that some mechanism other than the renin system causes sodium retention in nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3775238" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : A study on oedema mechanism in nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6392692" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Functional relationships in the nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6377881" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Renin-angiotensin-aldosterone system in nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6848563" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3317090" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Renal function during recovery from minimal lesions nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7321524" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Spectrum of acute renal failure in nephrotic syndrome with minimal (or minor) glomerular lesions. Role of hemodynamic factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25488894" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Nephrosclerosis: update on a centenarian.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27401688" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : The Substantial Loss of Nephrons in Healthy Human Kidneys with Aging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19443626" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Renal biopsy in the very elderly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10692269" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Etiologies and outcome of acute renal insufficiency in older adults: a renal biopsy study of 259 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21332335" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Acute kidney injury in adult idiopathic nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15861346" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Increased endothelin 1 expression in adult-onset minimal change nephropathy with acute renal failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28089478" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15909598" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Cyclooxygenase-2 inhibitor-associated minimal-change disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6363936" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Renal syndromes associated with nonsteroidal antiinflammatory drugs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12953043" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Secondary minimal change disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19585463" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Selective and non-selective non-steroidal anti-inflammatory drugs and the risk of acute kidney injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/503131" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Reversible renal failure and nephrotic syndrome associated with nonsteroidal anti-inflammatory drugs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7631049" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Interstitial nephritis, the nephrotic syndrome, and chronic renal failure secondary to nonsteroidal anti-inflammatory drugs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7350877" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Reversible rapidly progressive renal failure with nephrotic syndrome due to fenoprofen calcium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/496101" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Nephrotic syndrome: vasoconstriction and hypervolemic types indicated by renin-sodium profiling.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11158391" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Pathophysiology of acute renal failure in idiopatic nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11070714" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : [Acute renal failure in children with idiopathic nephrotic syndrome].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26450933" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : AKI in Children Hospitalized with Nephrotic Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5921344" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Hypovolemic shock complicating the nephrotic syndrome in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20724332" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Abdominal pain and vomiting in a boy with nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8941579" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Renal sodium handling in children with nephrotic relapse: relation to hypovolaemic symptoms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11021002" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Hypovolemia and hypovolemic shock in children with nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24037143" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Increasing frequency of acute kidney injury amongst children hospitalized with nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14579139" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Acute renal failure in children with idiopathic nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11149120" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Peritonitis as a risk factor of acute renal failure in nephrotic children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7965423" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Reversible idiopathic acute renal failure in children with primary nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30288260" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Acute kidney injury in children with nephrotic syndrome: a single-center study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14981597" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : ARF in children with minimal change nephrotic syndrome may be related to functional changes of the glomerular basal membrane.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31416888" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Risk of Nephrotic Syndrome for Non-Steroidal Anti-Inflammatory Drug Users.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8672009" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Does it make sense to administer albumin to the patient with nephrotic oedema?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8941578" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Long-term outcome of adult-onset minimal-change nephropathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/952293" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Irreversible acute renal failure in idiopathic nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2658558" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
